Characterization of fibulin-3 effects reveals reduced immunosuppressive signaling and enhanced macrophage activation in glioblastoma.
Figure S5. Characterization of fibulin-3 effects and anti-fibulin-3 targeting in fibulin-3-null cells.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: